封面
市場調查報告書
商品編碼
1186784

人工呼吸器的全球市場預測(2022年~2027年)

Global Mechanical Ventilator Market - Forecasts from 2022 to 2027

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 146 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球人工呼吸器的市場規模,2020年為31億8,600萬美金,在預測期間內預計以3.18%的年複合成長率成長,2027年成為39億6,700萬美元。

本報告提供全球人工呼吸器市場相關調查,市場規模和預測,COVID-19影響,市場促進因素及課題,市場趨勢,各市場區隔的市場分析,競爭情形,主要企業的簡介等系統性資訊。

目錄

第1章 簡介

  • 市場概要
  • COVID-19影響
  • 市場定義
  • 市場區隔

第2章 調查手法

  • 調查資料
  • 前提條件

第3章 摘要整理

  • 調查的重點

第4章 市場動態

  • 推動市場要素
  • 阻礙市場要素
  • 波特的五力分析
    • 供給企業談判力
    • 買方議價能力
    • 新加入廠商的威脅
    • 替代品的威脅
    • 競爭企業間的敵對關係
  • 產業的價值鏈分析

第5章 全球人工呼吸器市場:各類型

  • 簡介
  • 加護治療用
  • 攜帶用
  • 其他

第6章 全球人工呼吸器市場:各模式

  • 簡介
  • 容量
  • 壓力
  • 雙重
  • 互動
  • 其他

第7章 全球人工呼吸器市場:各技術

  • 侵入性
  • 非侵入性

第8章 全球人工呼吸器市場:各終端用戶

  • 簡介
  • 醫院
  • 診療所
  • 居家醫療
  • 其他

第9章 全球人工呼吸器市場:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 南美
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他
  • 中東、非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 印度
    • 越南
    • 印尼
    • 台灣
    • 其他

第10章 競爭環境與分析

  • 主要企業策略分析
  • 新興企業與市場的有利性
  • 合併,收購,契約,合作
  • 供應商的競爭矩陣

第11章 企業簡介

  • Dragerwerk AG
  • Philips Healthcare
  • Hamilton Medical AG
  • Fisher and Paykel Healthcare Limited
  • GE Healthcare
  • Medtronic Plc
  • ResMed Inc.
  • HEYER Medical AG
  • VYAIRE
  • ZOLL Medical Corporation
簡介目錄
Product Code: KSI061610590

Global mechanical ventilator market is projected to grow at a CAGR of 3.18% during the forecast period to reach US$3.967 billion by 2027, from US$3.186 billion in 2020.

A mechanical ventilator is a machine that helps a patient in breathing when he or she is finding it difficult to breathe due to surgery or critical illness of the patient. The patient is connected to a ventilator with a tube that goes into their mouth and down into their trachea. The patients are kept on a ventilator to improve their breathing conditions. It provides oxygen to the patients and removes carbon dioxide from the body. This process takes place under the supervision of a physician, registered nurse, or therapist.

The increase in the global mechanical ventilator market is due to increasing pollution and respiratory diseases.

Mechanical Ventilation is a life-saving therapy for patients with respiratory problems and critical illness. According to National Healthcare Safety Network (NHSN), and CDC, more than 300,000 patients receive mechanical ventilation each year in the US. The rise in pollution is one of the key drivers for the growth in the mechanical ventilator market. Air pollution, typically inhaling air pollutants in the body poses a serious risk of pulmonary disease. The smaller particles of pollutants cause deeper and greater penetration into the respiratory system.

According to (NCBI) National Centre for Biotechnology Information, Pub Med Central, long-term ozone and PM 2.5 exposure are associated with ARDS (acute respiratory distress syndrome) in old people in the United States. As per UNEP (United Nations Environment Programme), exposure to outdoor air pollution poses a threat to the environment and increases the risk of premature death. For example, air pollution is the reason for 20% of ischemic heart disease deaths globally but causes more than 30% of deaths in the Middle East and North Africa regions. Additionally, 20% of newborn deaths are attributed to air pollution worldwide.

Another reason for the increase in the use of a mechanical ventilator is Chronic Obstructive Pulmonary Disease (COPD) which includes bronchitis and emphysema. As per the National Library of Medicine (NCBI), it was the sixth most common cause of death in 1990 and became the third most common cause of death in 2020. Asthma, bronchiectasis, and bronchiolitis are other respiratory illnesses. Another reason for the use of mechanical ventilators is smoking. As per OECD, respiratory diseases in all EU countries are 85% higher among men than among women due to smoking habits.

However, there are major drawbacks associated with mechanical ventilators. For example, long-duration exposure to ventilators can cause pneumonia in patients. Lungs can damage as a result of the pressure of putting air in the lungs since very high levels of oxygen may be harmful to the lungs, a side effect of medications. Furthermore, in developing countries like India use of low-cost and outdated mechanical ventilators can pose a serious problem to the health of patients.

Key Development

Masimo Corporation acquired TNI Medical, a German company in March 2020. This acquisition was to capitalize on the softFlow technology of Masimo that provided high flow, warm, and humified respiratory gases to patients with pulmonary diseases and patients suffering from COVID-19.

Air Liquide, a home healthcare business in Europe acquired Betamed S.A, a major healthcare provider in Poland, in October 2021 This acquisition strengthened the presence of Air Liquide in Poland and expanded its services to support patients suffering from chronic respiratory diseases.

Medtech firm Inspiration Healthcare acquired Neonatal Ventilation product provider SLE Limited in June 2020 for 18 million Pounds. This acquisition was to increase the revenue of Inspiration Healthcare and expand its business and distribution network in the Middle East and Asia Pacific.

OES Medical - a UK manufacturer of anesthesia equipment launched a mains-powered ICU Ventilator in January 2022 at ABHI UK Pavilion at Arab Health 2022, for hospitals to manage their oxygen demand. The model Gemini-100 was designed to use in situations where high pressure of Oxygen gas supplies becomes problematic.

During the forecast period, North America is expected to acquire a significant portion in the global mechanical ventilator market.

North America, particularly the USA, captures higher market shares in the global mechanical ventilator market. The increase in respiratory illnesses and smoking habits contributed to the growth of mechanical ventilators in the market. According to American Lung Association, more than 20 million people each year suffer from respiratory illness, particularly lung diseases. Lung Cancer is a common problem among men and women in the USA and approximately two-thirds of the people are diagnosed with lung cancer due to smoking habits. The most common use of ventilators in the USA is in ICUs (Intensive Healthcare units), whereas at-home ventilators are used to control indoor pollution in homes and in clinics. USA MedTech giant Becton Dickinson is among the largest manufacturer of ventilators followed by Philips and Hamilton Medical.

COVID-19 Insights

COVID-19 had a significant impact on the global mechanical ventilator Market. A ventilator aids in the breathing process of patients who stay in the ICU (Intensive Care Unit). There was an increase in the use of mechanical ventilators during COVID-19 as many people faced breathing problems followed by low levels of oxygen. Patients with COVID-19 were prone to hypoxemia in ICU and showed an increase in the need for ventilators. Hospitals were the major user of ventilators. Furthermore, the rise in respiratory problems followed by millions of deaths worldwide increased the demand for mechanical ventilators which even created a shortage. The use of mechanical ventilators was more among adults, particularly middle-aged adults and infants. As per (NCBI) National Center for Biotechnology Information, there was a 31.5 % increase in ventilators in 2020 in the USA.

Market Segmentation:

By Type

Intensive Care

Portable

Others

By Mode

Volume

Pressure

Dual

Interactive

Others

By Technique

Invasive

Non-Invasive

By End User

Hospitals

Clinics

Homecare

Others

By Geography

North America

USA

Canada

Mexico

South America

Brazil

Argentina

Others

Europe

Germany

France

United Kingdom

Spain

Italy

Others

The Middle East and Africa

Saudi Arabia

UAE

Israel

Others

Asia Pacific

China

Japan

South Korea

India

Vietnam

Indonesia

Taiwan

Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. COVID-19 Scenario
  • 1.3. Market Definition
  • 1.4. Market Segmentation

2. RESEARCH METHODOLOGY

  • 2.1. Research Data
  • 2.2. Assumptions

3. EXECUTIVE SUMMARY

  • 3.1. Research Highlights

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Force Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. GLOBAL MECHANICAL VENTILATOR MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Intensive Care
  • 5.3. Portable
  • 5.4. Others

6. GLOBAL MECHANICAL VENTILATOR MARKET BY MODE

  • 6.1. Introduction
  • 6.2. Volume
  • 6.3. Pressure
  • 6.4. Dual
  • 6.5. Interactive
  • 6.6. Others

7. GLOBAL MECHANICAL VENTILATOR MARKET BY TECHNIQUE

  • 7.1. Invasive
  • 7.2. Non-Invasive

8. GLOBAL MECHANICAL VENTILATOR MARKET, BY END-USER

  • 8.1. Introduction
  • 8.2. Hospitals
  • 8.3. Clinics
  • 8.4. Homecare
  • 8.5. Others

9. GLOBAL MECHANICAL VENTILATOR MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. United States
    • 9.2.2. Canada
    • 9.2.3. Mexico
  • 9.3. South America
    • 9.3.1. Brazil
    • 9.3.2. Argentina
    • 9.3.3. Others
  • 9.4. Europe
    • 9.4.1. Germany
    • 9.4.2. France
    • 9.4.3. United Kingdom
    • 9.4.4. Spain
    • 9.4.5. Italy
    • 9.4.6. Others
  • 9.5. The Middle East and Africa
    • 9.5.1. Saudi Arabia
    • 9.5.2. UAE
    • 9.5.3. Israel
    • 9.5.4. Others
  • 9.6. Asia Pacific
    • 9.6.1. China
    • 9.6.2. Japan
    • 9.6.3. South Korea
    • 9.6.4. India
    • 9.6.5. Vietnam
    • 9.6.6. Indonesia
    • 9.6.7. Taiwan
    • 9.6.8. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Emerging Players and Market Lucrative
  • 10.3. Mergers, Acquisition, Agreements, and Collaborations
  • 10.4. Vendor Competitiveness Matrix

11. COMPANY PROFILES

  • 11.1. Dragerwerk AG
  • 11.2. Philips Healthcare
  • 11.3. Hamilton Medical AG
  • 11.4. Fisher and Paykel Healthcare Limited
  • 11.5. GE Healthcare
  • 11.6. Medtronic Plc
  • 11.7. ResMed Inc.
  • 11.8. HEYER Medical AG
  • 11.9. VYAIRE
  • 11.10. ZOLL Medical Corporation